Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
palifosfamide (Zymafos) (ZIO-201 oral)
print preview
bookmark
share with colleague
General Information
Company
Ziopharm Oncology Inc.
Description
Oral DNA cross-linker in the class of bendamine ifosfamide and cyclophosphamide
Molecular Target
DNA
Mechanism of Action
Alkylating agent
Latest Stage of Development
IND
Indication
Solid tumors
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy